Compare

Collagen Peptides vs VIP

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Last reviewed . By the PeptIQ team.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

Collagen Peptides

1220 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 44% · Mixed 40% · Unfavorable overall 16%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Sleep quality
7
Lean mass
11
Joint comfort
-146
Recovery
-121
Digestive comfort
-73

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Water retention
-77
Appetite loss
-90
Injection site reaction
-1
Anxiety
-125
Flushing
-73

Self-reported dose per injection

Median bucket: 100–200 mcg · Most common: 100–200 mcg

Reports span 10–1000 mcg

10–25
3
25–50
10
50–100
12
100–200
17
200–400
9
400–600
10
600–1000
3

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing24stacking37side effects10collagen peptides28

How repeat users are trending

Among repeat reporters, 54% said they felt similar to their last entry, 36% more positive, and 14% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 34 days · Based on 268 repeat reporters

VIP

1613 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 47% · Mixed 40% · Unfavorable overall 13%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Lean mass
180
Joint comfort
100
Recovery
90
Digestive comfort
44
Skin appearance
173

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Appetite loss
96
Injection site reaction
180
Anxiety
55
Flushing
39
Headache
172

Self-reported dose per injection

Median bucket: 0.2–0.4 mg · Most common: 0.2–0.4 mg

Reports span 0.01–2 mg

0.01–0.025 mg
2
0.025–0.05 mg
10
0.05–0.1 mg
13
0.1–0.2 mg
23
0.2–0.4 mg
27
0.4–0.6 mg
23
0.6–1 mg
13
1–2 mg
9

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing17stacking15side effects13vip21

How repeat users are trending

Among repeat reporters, 57% said they felt similar to their last entry, 45% more positive, and 17% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 19 days · Based on 355 repeat reporters

Sources (13)

Published sources linked on the Collagen Peptides and VIP wiki pages.

  1. PubMed

    Oral intake of specific bioactive collagen peptides reduces skin wrinkles and improves dermal matrix synthesis

    Proksch E, Schunck M, Zague V, et al. Skin Pharmacol Physiol. 2014

    Source
    Wiki study page →
  2. PubMed

    Collagen supplementation for osteoarthritis: a systematic review and meta-analysis

    García-Coronado JM, Martínez-Olvera L, Elizondo-Omaña RE, et al. Int Orthop. 2019

    Source
    Wiki study page →
  3. PubMed

    Daily oral supplementation with collagen peptides combined with vitamins and other bioactive compounds improves skin elasticity and has a beneficial effect on joint and general wellbeing

    Czajka A, Kania EM, Genovese L, et al. Nutrition research (New York, N.Y.). 2018

    Source
    Wiki study page →
  4. PubMed

    Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

    Ghatei MA, Takahashi K, Suzuki H, et al. J Cardiovasc Pharmacol. 2003

    Source
    Wiki study page →
  5. PubMed

    Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

    Delgado M, Chorny A, Gonzalez-Rey E, et al. J Leukoc Biol. 2005

    Source
    Wiki study page →
  6. PubMed

    Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions

    Delgado M, Ganea D. Amino Acids. 2013

    Source
    Wiki study page →
  7. PubMed

    Vasoactive intestinal peptide: cardiovascular effects

    Henning RJ, Sawmiller DR. Cardiovascular Research. 2001

    Source
    Wiki study page →
  8. PubMed

    Vasoactive intestinal peptide and the mammalian circadian system

    Vosko AM, Schroeder A, Loh DH, et al. General and Comparative Endocrinology. 2007

    Source
    Wiki study page →
  9. PubMed

    New perspectives on vasoactive intestinal polypeptide as a widespread modulator of social behavior

    Kingsbury MA. Current Opinion in Behavioral Sciences. 2015

    Source
    Wiki study page →
  10. ClinicalTrials.gov

    Vasoactive Intestinal Peptide studies on ClinicalTrials.gov

    ClinicalTrials.gov. Clinical trial registry. 2024

    Source
    Wiki study page →
  11. PubMed

    The significance of vasoactive intestinal peptide in immunomodulation

    Delgado M, Pozo D, Ganea D. Pharmacological reviews. 2004

    Source
    Wiki study page →
  12. PubMed

    Role of vasoactive intestinal peptide in osteoarthritis

    Jiang W, Wang H, Li YS, et al. Journal of biomedical science. 2016

    Source
    Wiki study page →